Tamsquare-D

**Tamsquare-D** is an oral fixed-dose combination product marketed by **Golden Square** in India for **benign prostatic hyperplasia**. It contains **tamsulosin 0.4 mg** and **dutasteride 0.5 mg**, both **small molecules**. Tamsulosin is an **alpha-1 adrenergic receptor antagonist** that relaxes smooth muscle in the prostate and bladder neck to improve urinary flow, while dutasteride is a **5-alpha-reductase inhibitor** that lowers dihydrotestosterone synthesis and helps reduce prostate volume. The product is positioned as a symptomatic and disease-modifying combination treatment for men with enlarged prostate associated lower urinary tract symptoms.

Brand names

Tamsquare-D

Other names

tamsulosin + dutasteride